Form 8-K AbbVie Inc. For: Jul 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/24/2026
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
- Americold to wind down Ahold Delhaize facilities, take $305M charge
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Did Google and Tesla just break AI trade’s bull case?
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
- Matador Resources to acquire Paloma Permian for $1.275B
AbbVie updates 2026 EPS guidance after $291M IPR&D charge
July 6, 2026 4:14 PM EDTAbbVie (NYSE: ABBV) has disclosed a $291 million pre-tax acquired in-process research and development (IPR&D) and milestones expense for the second quarter of 2026, which the company says will reduce both GAAP and adjusted non-GAAP diluted earnings per share by $0.17.
The company noted that... More
